Close Menu

You may find more results for this query on our sister sites: GenomeWeb and 360Dx.

Home › About Us › Our Staff › Andrea Anderson

Andrea Anderson

Contributor
Phone Number
+1-780-990-0086
Email
[email protected]
Andrea Anderson Andrea Anderson

Andrea Anderson covers genomics research studies and translational research for GenomeWeb. Find her on Twitter at @andyandy_tk.

Articles Authored by Andrea Anderson

Jul 02, 2020

GNS Healthcare, MMRF Bring Patient Simulations to Multiple Myeloma Precision Treatment, Trial Design

Premium

Investigators plan to tap into large genomic and other datasets with an in silico patient to simulate drug responses, uncover treatment targets, and assess therapies.

Jun 04, 2020

PARP Inhibitor Response Markers Still Key Consideration in Ovarian Cancer Despite Broad Indications

Premium

With studies showing BRCA-mutated patients have a greater magnitude of benefit, oncologists grapple with complex treatment decisions in BRCA mutation-free cases.

Jun 03, 2020

Veterans With Targetable Mutations in Lung Cancer Not Getting Right Rx, Study Finds

The gap in care suggests that more education and decision support tools are needed to help physicians prescribe drugs based on highly actionable tumor alterations, researchers said.

Jun 03, 2020

BFOR Study Uses Digital Tools to Facilitate Population BRCA Screening in Ashkenazi Jewish Community

Results show population screening can pick up risky BRCA1/2 mutations in men and women from Ashkenazi Jewish populations in the US, though engagement challenges remain.

Jun 01, 2020

MET Tyrosine Kinase Inhibitor Shows 'Encouraging' Efficacy in Phase III Kidney Cancer Trial

Though enrollment for the SAVOIR trial stopped early, results suggest that MET-driven advanced papillary renal cell carcinomas respond to savolitinib.

May 31, 2020

Polygenic Risk Score, Family History Refine Breast Cancer Risk Assessment in CHEK2 Mutation Carriers

Breast cancer risk in carriers of pathogenic CHEK2 variants may be classified as low, moderate, or high by adding in polygenic risk score and family history data.

May 15, 2020

NHGRI-Funded KidsCanSeq Study Brings Clinical Sequencing to Texas Hospitals

Premium

The effort will compare clinical sequencing strategies and explore best practices for educating participants and applying the results to patient care.

May 14, 2020

AstraZeneca's Lynparza Gives Survival Boost as Maintenance in Relapsed BRCA-Mutated Ovarian Cancer

The survival data from the Phase III SOLO2 trial confirms to experts that olaparib should be the standard of care maintenance therapy for patients in this setting.

May 05, 2020

Invitae Study Finds Germline Risk Variants in Wide Range of Prostate Cancer Patients

Data presented at ACMG's online annual meeting suggests that more than 10 percent of prostate cancer patients across disease stages carry inherited cancer-related variants.

May 01, 2020

NCI-MATCH Data Points to Possible Role for Mutated NRAS Codon in MEK Inhibitor Response

Early sub-protocol results presented at AACR meeting hint at better outcomes for Mektovi-treated cases with NRAS codon 61 tumor mutations.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.